AEWIN Technologies Co.Ltd. (3564.TWO) stock: key figures, P/E, revenue and dividend
Information Technology · Technology Hardware, Storage & Peripherals · Taiwan
AEWIN Technologies Co.Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.29 bn TWD | 2.50 bn TWD |
| Gross profit | 590.94 m TWD | 572.47 m TWD |
| Operating income | 106.39 m TWD | 53.04 m TWD |
| EBIT | 88.50 m TWD | 73.21 m TWD |
| Net income | 52.87 m TWD | 38.35 m TWD |
| Diluted EPS – continuing operations | 0.89 TWD | 0.65 TWD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AEWIN Technologies Co.Ltd.
AEWIN Technologies Co.,Ltd. engages in the design, manufacture, and sale of network security-related products in Asia, the United States, and Europe. The company offers network appliances; general purpose and edge computing servers, and workstations; network expansion modules; functional modules; and standard PCIe cards, including network interface, QAT crypto acceleration, OCP QAT, and storage adapter cards. It also provides workload optimization systems and Edge AI solutions; and ODM/OEM services. The company's products are used for network computing, software-defined wide area network, network functions virtualization infrastructure, multi-access edge computing/edge AI, and 5G/vRAN applications. The company was founded in 1989 and is based in New Taipei City, Taiwan.
More stocks
- Zomedica Corp. (ZOMDF)
- Anterogen.Co.Ltd (065660.KQ)
- CURATIS N AG (CURN.SW)
- Perspective Therapeutics, Inc. (CATX)
- SPSoft Inc. (443670.KQ)
- Shinhung (004080.KS)
- Patria Bank SA (PBK.RO)
- Pharmosa Biopharm Inc. (6875.TWO)
- Chin Hsin Environ Engineering Co., Ltd. (6951.TW)
- Unicycive Therapeutics, Inc. (UNCY)
- QUALITAS SEMICONDUCTOR CO. LTD. (432720.KQ)
- GEORGE RISK INDUSTRIES, INC. (RSKIA)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.